The 4100 Group

From seed-stage ventures to strategic buyouts, we leverage our expertise to provide financial backing to innovative startups and established companies alike. We fuel their growth and facilitate the development of groundbreaking health-related products and other advancements aimed at improving global wellness. Our investable capital base—established through both permanent capital vehicles and more traditional funds—enables us to forge enduring partnerships with visionary leaders in the industry. Together, we redefine categories, cultivate exceptional companies, and drive the development of uniquely innovative products. FOCUS ▪ Care Convergence We see a trend in healthcare where professionals extend their expertise beyond traditional boundaries, offering holistic services that address a broader spectrum of patient needs. ▪ Patient-Centric Innovation Our investments directly impact the quadruple aim and represent a balance of clinical, economic, and humanistic factors in the interest of creating both immediate and future shared value. ▪ Pioneering Therapeutics & Technology Powered by patient capital, we propel the advancement of computationally advanced platforms for drug discovery, optimization, repurposing, and delivery.